Professional Seasonal Analysis for Trading

Xenon Pharmaceuticals Inc. - Common Shares (XENE)

Seasonality Analysis

Stocks 12 Years Analyzed

Xenon Pharmaceuticals Inc. - Common Shares Annual Seasonality Statistics

27.55%
Avg Annual Return
48.2%
Avg Monthly Win Rate
9/12
Positive Months
12
Years Analyzed

Xenon Pharmaceuticals Inc. - Common Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 0.75%
50%
Weak
February 6.24%
83%
Very Strong
March -5.08%
25%
Very Weak
April 3.20%
50%
Weak
May -3.49%
27%
Very Weak
June 2.32%
45%
Weak
July 2.04%
45%
Weak
August 7.17%
64%
Strong
September WORST -6.77%
18%
Very Weak
October 5.93%
45%
Weak
November 4.15%
58%
Moderate
December BEST 11.09%
67%
Strong

Xenon Pharmaceuticals Inc. - Common Shares 2026 vs Historical Pattern

Current Position
83.85
Historical Avg Position
36.67
Deviation
+47.17
Performance
Significantly Above Average

Xenon Pharmaceuticals Inc. - Common Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for XENE with overlay patterns, custom date ranges, and more.

Create Free Account

Xenon Pharmaceuticals Inc. - Common Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Xenon Pharmaceuticals Inc. - Common Shares Seasonal Historical Performance

Historical Performance

See historical average returns for XENE across multiple timeframes.

Create Free Account

About Xenon Pharmaceuticals Inc. - Common Shares (XENE) Seasonality

Xenon Pharmaceuticals Inc. - Common Shares (XENE) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Xenon Pharmaceuticals Inc. - Common Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Xenon Pharmaceuticals Inc. - Common Shares is historically December, with an average return of 11.09% and a win rate of 67%. Conversely, September tends to be the weakest month, averaging -6.77% return.

Looking at the full calendar year, Xenon Pharmaceuticals Inc. - Common Shares has an average annual return of 27.55% with an overall monthly win rate of 48.2%. Out of 12 months, 9 typically show positive average returns.

The seasonal pattern for Xenon Pharmaceuticals Inc. - Common Shares has a consistency score of 41.1 (Poor), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Xenon Pharmaceuticals Inc. - Common Shares Seasonality FAQ

What is the best month to buy Xenon Pharmaceuticals Inc. - Common Shares (XENE)?

Historically, December has been the best month for Xenon Pharmaceuticals Inc. - Common Shares, with an average return of 11.09% and a win rate of 67%. However, past performance does not guarantee future results.

What is the worst month for Xenon Pharmaceuticals Inc. - Common Shares (XENE)?

Based on historical data, September has been the weakest month for Xenon Pharmaceuticals Inc. - Common Shares, with an average return of -6.77%. This is a historical observation and does not guarantee future results.

How reliable is XENE seasonality data?

The seasonality analysis for Xenon Pharmaceuticals Inc. - Common Shares is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Xenon Pharmaceuticals Inc. - Common Shares seasonality in my trading?

Use Xenon Pharmaceuticals Inc. - Common Shares (XENE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.